
- RIUMA Principal
- Listar por autor
Listar por autor "Ruiz-Medina, Sofía"
Mostrando ítems 1-3 de 3
-
Design and implementation of a standard care programme of therapeutic exercise and education for breast cancer survivors
Roldán-Jiménez, Cristina; Pajares, Bella; Ruiz-Medina, Sofía; Trinidad-Fernández, Manuel; González-Sánchez, Manuel
; Ribelles, Nuria; García-Almeida, José Manuel
; Ríos-López, María José; Alba-Conejo, Emilio
; Cuesta-Vargas, Antonio
[et al.] (SPRINGER, 2021-08-31)
Background Breast cancer survivors (BCS) face several symptoms and are at higher risk of weight gain following diagnosis. Current literature shows that both exercise and diet play a key role in recovery of BCS. However, ... -
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HRþ)/HER2-negative advanced breast cancer patients.
Ribelles, Nuria; Jerez-Aragonés, José Manuel; Rodríguez-Brazzarola, Pablo; Jiménez-Rodríguez, Begoña; Díaz-Redondo, Tamara; Mesa, Héctor; Márquez, Antonia; Sánchez-Muñoz, Alfonso
; Pajares, Bella; Carabantes, Francisco; Bermejo-Pérez, María José; Villar, Ester; Domínguez-Recio, María Emilia; Saez-Lara, Enrique; Gálvez Carvajal, Laura; Godoy-Ortiz, Ana; Franco, Leónardo
; Ruiz-Medina, Sofía; López, Irene; Alba-Conejo, Emilio
[et al.] (Elsevier, 2021)
Background: CDK4/6 inhibitors plus endocrine therapies are the current standard of care in the first-line treatment of HRþ/HER2-negative metastatic breast cancer, but there are no well-established clinical or molecular ...